CD8A and neoplasm: Our data show that amongst those de novo T cell reactivities there exists at least a subset of both helper CD4+ and heteroclitic CD8+ effector T cells36, 37, 55 which can cross react between AIRE-induced epitopes and similar epitopes on the parental tumour cells, leading to potent tumour rejection responses.